Glucose Health, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-10.
Glucose Health, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 10, 2026. The filing reports $10K sold. Its industry group is Manufacturing. It names Mark Schaftlein (Director), John Duffy (Executive Officer, Director), marc Hatch (Executive Officer) (SEC Form D, September 10, 2026).
Sell to companies like Glucose Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Glucose Health, Inc.
Free to see. No signup.
More on the people and the money behind Glucose Health, Inc., from the filings we hold.
Manufacturing raises filed within 90 days of this one, largest first.
Get an email when Glucose Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Glucose Health, Inc. raises, hires or launches. No email unless you switch it on.
Watch Glucose Health, Inc. →Get the full cited report on Glucose Health, Inc.
What the filing shows about Glucose Health, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Glucose Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Glucose Health, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 370 filings in Manufacturing, totalled by week. The dot is this raise, $10K, on the same scale — one filing against the whole group's total, so it sits low by construction.
By form type: 10-Q ×31 · 8-K ×25 · NT 10-Q ×11 · D ×9 · 10-K ×9 · UPLOAD ×8 · CORRESP ×8 · NT 10-K ×7, and others.
| Form | Filed | On EDGAR |
|---|---|---|
| D | 2026-09-10 | open |
| D | 2026-07-07 | open |
| D | 2026-02-04 | open |
| D | 2025-12-05 | open |
| D/A | 2024-01-19 | open |
| D | 2023-12-07 | open |
| RW | 2023-06-28 | open |
| S-1/A | 2023-01-09 | open |
| S-1/A | 2022-09-06 | open |
| S-1/A | 2022-08-05 | open |
What the filing shows about Glucose Health, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Glucose Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Glucose Health, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The 10 most recent of 136 filings on CIK 0001420108, filed as Glucose Health, Inc.. Read from the SEC's own submissions feed for this issuer, not from a third party. Incorporated in DE. Full history on sec.gov.
Mark Schaftlein is named as Director on the Form D that Glucose Health, Inc. filed with the SEC on 10 September 2026, one of 5 people that filing names.
John Duffy is named as Executive Officer and Director on the Form D that Glucose Health, Inc. filed with the SEC on 10 September 2026, one of 5 people that filing names.
marc Hatch is named as Executive Officer on the Form D that Glucose Health, Inc. filed with the SEC on 10 September 2026, one of 5 people that filing names.
Edmund Burke is named as Director on the Form D that Glucose Health, Inc. filed with the SEC on 10 September 2026, one of 5 people that filing names.
Christopher Jemapete is named as Director on the Form D that Glucose Health, Inc. filed with the SEC on 10 September 2026, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2026-09-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Glucose Health, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Glucose Health, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Glucose Health, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-09-07
https://mentionfox.com/funding/glucose-health-inc-form-d-000003